Search Results - "Faggiano, A."

Long-acting somatostatin analogs and well differentiated neuroendocrine tumors: a 20-year-old story by Faggiano, A.

“…Purpose The specific indications of somatostatin analogs (SSAs) in patients with neuroendocrine tumor (NET) emerged over the time. The objective of this review…”
Get full text

Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature by Fraenkel, M, Kim, M, Faggiano, A, de Herder, W W, Valk, G D

“…Based on the current medical literature, the worldwide incidence of neuroendocrine tumours (NETs) seems to have increased; however, a systematic literature…”
Get full text

Epidemiology of gastroenteropancreatic neuroendocrine tumours by Fraenkel, M., MD, Kim, M.K., MD, MSc, Faggiano, A., MD, PhD, Valk, G.D., MD, PhD

“…Abstract Gastroenteropancreatic neuroendocrine tumours are a heterogeneous group of tumours arising from diffuse endocrine cells, causing unique clinical…”
Get full text

Diabetes technology and sexual health: which role? by Zamponi, V., Haxhi, J., Pugliese, G., Faggiano, A., Mazzilli, R.

“…Purpose The aim of this review is to evaluate the effects of new technology used in the management of diabetes mellitus (DM), including the use of continuous…”
Get full text

Letter to the editor: how the COVID-19 pandemic has changed outpatient diagnosis in the andrological setting by Mazzilli, R., Zamponi, V., Faggiano, A.

Get full text

Erectile dysfunction as a marker of endocrine and glycemic disorders by Mazzilli, R., Zamponi, V., Olana, S., Mikovic, N., Cimadomo, D., Defeudis, G., Faggiano, A.

“…Purpose The aim of this study was to evaluate in a population of patients with erectile dysfunction (ED): (a) the prevalence of a previously unknown…”
Get full text

Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists by La Salvia, A., Modica, R., Rossi, R.E., Spada, F., Rinzivillo, M., Panzuto, F., Faggiano, A., Cinieri, S., Fazio, N.

“…•Two long-acting somatostatin analogs (SSA) are available in clinical practice for NET.•Octreotide and lanreotide are approved for clinical syndrome and tumor…”
Get full text

The effects of non-andrological medications on erectile dysfunction: a large single-center retrospective study by Mazzilli, R., Zamponi, V., Mangini, F., Olana, S., Defeudis, G., Faggiano, A., Gianfrilli, D.

“…Purpose To evaluate the association among andrological diseases at the first outpatient visit and the medications taken by patients for other comorbidities, as…”
Get full text

Rachel score: a nomogram model for predicting the prognosis of lung neuroendocrine tumors by La Salvia, A., Marcozzi, B., Manai, C., Mazzilli, R., Landi, L., Pallocca, M., Ciliberto, G., Cappuzzo, F., Faggiano, A.

“…Background Lung NET, classified in typical carcinoids (TC) and atypical carcinoids (AC), are highly heterogeneous in their biology and prognosis. The…”
Get full text

The role of thyroid function in female and male infertility: a narrative review by Mazzilli, R., Medenica, S., Di Tommaso, A. M., Fabozzi, G., Zamponi, V., Cimadomo, D., Rienzi, L., Ubaldi, F. M., Watanabe, M., Faggiano, A., La Vignera, S., Defeudis, G.

“…Purpose We herein aimed to review the new insights into the impact of impaired thyroid function on male and female fertility, spacing from spontaneous…”
Get full text

PRRT: identikit of the perfect patient by Albertelli, M., Dotto, A., Di Dato, C., Malandrino, P., Modica, R., Versari, A., Colao, A., Ferone, D., Faggiano, A.

“…Peptide receptor radionuclide therapy (PRRT) has been strengthened since the publication of NETTER-1. Nevertheless, the correct positioning in the therapeutic…”
Get full text

Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case–control study by Feola, T., Puliani, G., Sesti, F., Modica, R., Centello, R., Minotta, R., Cannavale, G., Di Meglio, S., Di Vito, V., Lauretta, R., Appetecchia, M., Colao, A., Lenzi, A., Isidori, A. M., Faggiano, A., Giannetta, E.

“…Purpose Risk factors for sporadic GEP-NENs are still not well defined. To identify the main clinical risk factors represents the aim of this study performed by…”
Get full text

Extracellular vesicles in cardiomyopathies: A narrative review by Rizzuto, A.S., Faggiano, A., Macchi, C., Carugo, S., Perrino, C., Ruscica, M.

“…Extracellular vesicles (EVs) are membrane-bound particles released by all cells under physiological and pathological conditions. EVs constitute a potential…”
Get full text

Selenium supplementation in the management of thyroid autoimmunity during pregnancy: results of the “SERENA study”, a randomized, double-blind, placebo-controlled trial by Mantovani, G., Isidori, A. M., Moretti, C., Di Dato, C., Greco, E., Ciolli, P., Bonomi, M., Petrone, L., Fumarola, A., Campagna, G., Vannucchi, G., Di Sante, S., Pozza, C., Faggiano, A., Lenzi, A., Giannetta, E.

“…Purpose Selenium is frequently in nutraceuticals for pregnancy, given its role on fertility and thyroid metabolism. However, most evidence rise from…”
Get full text

Thyroid Nodules Treated with Percutaneous Radiofrequency Thermal Ablation: A Comparative Study by Faggiano, A, Ramundo, V, Assanti, A. P, Fonderico, F, Macchia, P. E, Misso, C, Marciello, F, Marotta, V, Del Prete, M, Papini, E, Lombardi, G, Colao, A, Spiezia, S

“…Purpose: Percutaneous radiofrequency thermal ablation (RTA) was reported as an effective tool for the management of thyroid nodules (TNs). The aim of this…”
Get full text

Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study by Modica, R., Scandurra, C., Maldonato, N. M., Dolce, P., Dipietrangelo, G. G., Centello, R., Di Vito, V., Giannetta, E., Isidori, A. M., Lenzi, A., Faggiano, A., Colao, A.

“…Purpose Scientific knowledge on health-related quality of life (HRQoL) in patients with neuroendocrine neoplasm (NEN) is still limited and longitudinal…”
Get full text

The evolving field of kinase inhibitors in thyroid cancer by Marotta, V, Sciammarella, C, Vitale, M, Colao, A, Faggiano, A

“…Highlights • Genes with kinase activity are implicated in the pathogenesis of thyroid cancer. This provides the rationale for using KIs. • KIs are the most…”
Get full text

Clinico–pathological features, treatments and survival of malignant insulinomas: a multicenter study by Veltroni, A, Cosaro, E, Spada, F, Fazio, N, Faggiano, A, Colao, A, Pusceddu, S, Zatelli, M C, Campana, D, Piovesan, A, Pia, A, Grossrubatscher, E M, Filice, A, Bianchi, A, Razzore, P, Toaiari, M, Cingarlini, S, Landoni, L, Micciolo, R, Davì, M V

“…Introduction Management of malignant insulinomas is challenging due to the need to control both hypoglycaemic syndrome and tumor growth. Literature data is…”
Get full text

The safety of available treatments options for neuroendocrine tumors by Faggiano, A, Lo Calzo, F, Pizza, G, Modica, R, Colao, A

“…Neuroendocrine neoplasms (NEN) represent a heterogeneous group of malignancies generally characterized by low proliferation and indolent course. However, about…”
Get more information

Characterization of circulating immune cells and correlation with Tie2/Angiopoietins level in well differentiated neuroendocrine gastroenteropancreatic tumors: a cross-sectional analysis by Sesti, F., Puliani, G., Feola, T., Campolo, F., Sciarra, F., Hasenmajer, V., Lenzi, A., Faggiano, A., Isidori, A. M., Venneri, M. A., Giannetta, E.

“…Purpose The immune environment represents a new, but little explored, tool for understanding neuroendocrine neoplasms (NENs) behavior. An immunosuppressed…”
Get full text